Primary systemic amyloidosis with malignant pinch purpura: A case report

Authors

  • Dadanuch Sastararuji Institute of Dermatology, Ministry of Public Health, Bangkok
  • Tanawatt Kootiratrakarn Institute of Dermatology, Ministry of Public Health, Bangkok
  • Walaiorn Pratchyapruit Institute of Dermatology, Ministry of Public Health, Bangkok

Keywords:

primary systemic amyloidosis, pinch purpura

Abstract

Bilateral periorbital purpura (raccoon’s eyes) has been associated with many causes such as traumatic (basal skull fracture and rhinoplasty), neuroblastoma, lymphoma, kaposi’s sarcoma and primary systemic amyloidosis. We report 88-year-old man presented with a 6 months history of extensive periorbital hemorrhagic nodular plaques forming gross distortion which disturbed his eye-fields and numerous translucent and hyperpigment papules over trunk and back. Histopathologic study from the skin lesions at periorbital region and back showed amorphous eosinophilic material deposit in superficial to deep dermis and around blood vessel wall. After Congo red staining, the sample showed a red-green birefringence and dichroism under polarized light microscopy. Further work-up revealed free light chain (kappa) on urine protein electrophoresis and serum immunofixation electrophoresis showed IgG kappa monoclonal gammopathy. According to these findings, the diagnosis of primary systemic amyloidosis associated with plasma cell dyscrasia was made. In conclusion, this case presented with massive periorbital hemorrhagic nodular mass and numerous papular eruptions which were rarely seen in systemic amyloidosis. Malignant pinch purpura was shown as a crucial clue in the diagnosis of systemic amyloidosis in our patient who has no other systemic complaints.

References

1. Nienhuis HL, Bijzet J, Hazenberg BP. The prevalence and management of systemic amyloidosis in western countries. Kidney Dis (Basel) 2016; 2: 10-9.

2. Lebowitz RA, Morris L. Plasma cell dyscrasias and amyloidosis. Otolaryngologic Clin of North Am 2003; 36: 747-64.

3. Simms RW, Prout MN, Cohen AS. The epidemiology of AL and AA amyloidosis. Baillieres Clin Rheumatol 1994; 8: 627-34.

4. Kyle RA, Gertz MA. Primary systemic amyloidosis: clinical and laboratory features in 474 cases. Semin Hematol 1995; 32: 45-59.

5. Breathnach SM. Amyloid and amyloidosis. J Am Acad Dermatol 1988; 18: 1-16.

6. Pascali E. Diagnosis and treatment of primary amyloidosis. Crit Rev Oncol Hematol 1995; 19: 149- 81.

7. Iijima S. Primary systemic amyloidosis: a unique case complaining of diffuse eyelid swelling and conjunctival involvement. J Dermatol 1992; 19: 113- 8.

8. Pereira VG, Jacinto M, Santos J, de Abreu TT. Periorbital purpura (raccoon's eyes). BMJ Case Rep 2014; 2014.

9. Silverstein SR. Primary, systemic amyloidosis and the dermatologist: where classic skin lesions may provide the clue for early diagnosis. Dermatol Online J 2005; 11:5.

10. Wat H, Wu DC, Mahmood MN, Brassard A. Primary systemic (amyloid light-chain) amyloidosis masquerading as pseudoxanthoma elasticum: recognizing a novel clinicopathological pattern. JAMA dermatol 2014; 150: 1091-4.

11. Kyle RA, Gertz MA, Greipp PR, et al. A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine. N Eng J Med 1997; 336: 1202-7.

12. Skinner M, Anderson J, Simms R, et al. Treatment of 100 patients with primary amyloidosis: a randomized trial of melphalan, prednisone, and colchicine versus colchicine only. Am J Med 1996; 100: 290-8.

Downloads

Published

2017-09-01

How to Cite

Sastararuji, D., Kootiratrakarn, T., & Pratchyapruit, W. (2017). Primary systemic amyloidosis with malignant pinch purpura: A case report. Thai Journal of Dermatology, 33(3), 209–214. Retrieved from https://he02.tci-thaijo.org/index.php/TJD/article/view/159070